If CAR T-cell therapy isn't an option for you at home — or the wait is too long, or the criteria rule you out — you are not the first person to look further afield. Over the past few years, China has become one of the few places in the world where this treatment is widely available, delivered quickly, and offered at a fraction of Western cost. This page explains, honestly, why.
In much of Australia, New Zealand and Southeast Asia, CAR T-cell therapy is either unavailable, or available only under tight restrictions. Where it is funded, it is often limited to specific cancers and specific subtypes, reserved until several other treatments have already failed, and subject to waiting lists.
Patients with a diagnosis that falls outside the approved criteria — or who don't have time to wait — can find that a treatment they know exists is, in practice, out of reach.
New Zealand patients face the tightest limits of all — which is why a number of them have looked offshore.
The same class of treatment — delivered faster, and for far less.
China approved its first CAR T-cell therapy in 2021, four years after the United States — and in the years since, the range of approved therapies has caught up to what's available in the West.
China now runs more CAR T-cell clinical trials than any other country, which means a deep base of hospitals and clinicians with hands-on experience delivering it.
A relatively fast regulatory pathway and large-scale, domestic cell-manufacturing capacity are also why the same class of treatment can be delivered faster, and for far less, than in the United States.
Within China, SinoUnited Health is an international hospital in central Shanghai that has built its CAR T-cell program specifically around patients coming from overseas. It is among the first hospitals in Shanghai to hold China's International Medical Tourism Pilot Demonstration Base designation.
International Medical Tourism Pilot Demonstration Base — awarded specifically for the care of international patients.
More than 100 consultations to international patients, and more than 30 treated for blood cancers.
We won't sell the destination and hide the reality. Traveling for treatment is a serious undertaking — here is what it actually asks of you.
Traveling for treatment typically means two trips to Shanghai over roughly two months, a companion traveling with you, and coordination with your own oncologist at home both before you go and after you return. A dedicated English-speaking team handles the logistics — records review, scheduling, airport pickup, translation, and staying in contact with your home physician — so that the medical decisions stay with the clinicians and the practical load stays off you.
One short trip for cell collection, one longer stay for infusion and monitoring.
Bring someone. In China, family provides day-to-day support during a hospital stay — every ward has a sofa bed for them.
Your own oncologist is kept in the loop before you travel and after you return.
Start a free remote assessment, and the team will tell you whether CAR T-cell therapy may be an option for you.
Inside the CAR-T program · Dr. Lily Zhou and SinoUnited Health leadership · 2 min